Laminin regulates PI3K basal localization and activation to sustain STAT5 activation

Ren Xu; Virginia A. Spencer; Dinah Levy Groesser; Mina J. Bissell

doi:10.4161/cc.9.21.13578

Laminin regulates PI3K basal localization and activation to sustain STAT5 activation

Ren Xu
, Virginia A. Spencer
, Dinah Levy Groesser
, Mina J. Bissell

Pharmacology and Nutritional Sciences

Producción científica: Article › revisión exhaustiva

34 Citas (Scopus)

Resumen

Extracellular matrix (ECM) is a key regulator of tissue morphogenesis and functional differentiation in the mammary gland. We showed recently that laminin-111 (LN1) together with prolactin induces β-casein expression in mammary epithelial cells (MECs) by sustaining STAT5 activation. Others have shown that Rac1 is required for integrin-mediated STAT5 activation, but molecules upstream of Rac1 remain to be elucidated. Here, we show that exposure to three-dimensional (3D) laminin-rich ECM (LrECM) gels changes the localization of phosphoinositide 3-kinase (PI3K) in MECs from diffuse to basal accompanied with the activation of PI3K-Rac1 signaling pathway. We show by co-immunoprecipitation that Rac1 associates with STAT5, and that LrECM treatment enhances this interaction. Blocking PI3K with LY294002 inhibits LrECM-dependent Rac1 activation, attenuates sustained STAT5 phosphorylation and blocks β-casein gene transcription. These results indicate that PI3K is a key mediator of the LN1-induced signaling cascade which controls the activity of transcription factors essential for tissue-specific gene expression.

Idioma original	English
Páginas (desde-hasta)	4315-4322
Número de páginas	8
Publicación	Cell Cycle
Volumen	9
N.º	21
DOI	https://doi.org/10.4161/cc.9.21.13578
Estado	Published - nov 1 2010

Nota bibliográfica

Funding Information:
We thank Dr. Masahiko Itoh (Dokkyo University Tochigi prefecture, Japan) for providing the ZO-1 antibody. The construct containing STAT5A 1*6 was a kind gift from Dr. Toshio Kitamura (University of Tokyo, Japan). This work was supported by grants from the US Department of Energy, the Office of Biological and Environmental Research (contract no. DE-AC02-05CH1123), a Low Dose Radiation Program and a Distinguished Fellow Award from the Office of Health and Environmental Research Health Effects Division (contract no. 03-76SF00098) to M.J.B., the National Cancer Institute (awards R01CA064786, U54CA126552 and U54CA112970 to M.J.B. and R01CA057621 to M.J.B. and Zena Werb), the US Department of Defense Medical and Materiel Command Innovator Award (contract no.W81XWH0810736 and W81XWH0510338) to M.J.B. and postdoctoral fellowships DAMD17-02-1-0441 to R.X. and W81XWH0410581 to V.A.S. and a post-doctoral fellowship to V.A.S. from the Canadian Institutes of Health Research.

Financiación

We thank Dr. Masahiko Itoh (Dokkyo University Tochigi prefecture, Japan) for providing the ZO-1 antibody. The construct containing STAT5A 1*6 was a kind gift from Dr. Toshio Kitamura (University of Tokyo, Japan). This work was supported by grants from the US Department of Energy, the Office of Biological and Environmental Research (contract no. DE-AC02-05CH1123), a Low Dose Radiation Program and a Distinguished Fellow Award from the Office of Health and Environmental Research Health Effects Division (contract no. 03-76SF00098) to M.J.B., the National Cancer Institute (awards R01CA064786, U54CA126552 and U54CA112970 to M.J.B. and R01CA057621 to M.J.B. and Zena Werb), the US Department of Defense Medical and Materiel Command Innovator Award (contract no.W81XWH0810736 and W81XWH0510338) to M.J.B. and postdoctoral fellowships DAMD17-02-1-0441 to R.X. and W81XWH0410581 to V.A.S. and a post-doctoral fellowship to V.A.S. from the Canadian Institutes of Health Research.

Financiadores	Número del financiador
Office of Health and Environmental Research Health Effects Division	03-76SF00098
US Department of Defense Medical and Materiel Command Innovator Award	no.W81XWH0810736, W81XWH0510338, W81XWH0410581, DAMD17-02-1-0441
Michigan State University-U.S. Department of Energy (MSU-DOE) Plant Research Laboratory
National Childhood Cancer Registry – National Cancer Institute	R01CA057621, R01CA064786, U54CA112970, U54CA126552
Biological and Environmental Research	DE-AC02-05CH1123
Canadian Institutes of Health Research

ASJC Scopus subject areas

Molecular Biology
Developmental Biology
Cell Biology

Acceder al documento

10.4161/cc.9.21.13578

Otros archivos y enlaces

Citar esto

@article{6bb903c2333045b9b1adf8d5afbdc588,

title = "Laminin regulates PI3K basal localization and activation to sustain STAT5 activation",

abstract = "Extracellular matrix (ECM) is a key regulator of tissue morphogenesis and functional differentiation in the mammary gland. We showed recently that laminin-111 (LN1) together with prolactin induces β-casein expression in mammary epithelial cells (MECs) by sustaining STAT5 activation. Others have shown that Rac1 is required for integrin-mediated STAT5 activation, but molecules upstream of Rac1 remain to be elucidated. Here, we show that exposure to three-dimensional (3D) laminin-rich ECM (LrECM) gels changes the localization of phosphoinositide 3-kinase (PI3K) in MECs from diffuse to basal accompanied with the activation of PI3K-Rac1 signaling pathway. We show by co-immunoprecipitation that Rac1 associates with STAT5, and that LrECM treatment enhances this interaction. Blocking PI3K with LY294002 inhibits LrECM-dependent Rac1 activation, attenuates sustained STAT5 phosphorylation and blocks β-casein gene transcription. These results indicate that PI3K is a key mediator of the LN1-induced signaling cascade which controls the activity of transcription factors essential for tissue-specific gene expression.",

keywords = "Laminin, PI3K-Rac1 pathway, Polarity, Sustained STAT5 activation",

author = "Ren Xu and Spencer, \{Virginia A.\} and Groesser, \{Dinah Levy\} and Bissell, \{Mina J.\}",

note = "Funding Information: We thank Dr. Masahiko Itoh (Dokkyo University Tochigi prefecture, Japan) for providing the ZO-1 antibody. The construct containing STAT5A 1*6 was a kind gift from Dr. Toshio Kitamura (University of Tokyo, Japan). This work was supported by grants from the US Department of Energy, the Office of Biological and Environmental Research (contract no. DE-AC02-05CH1123), a Low Dose Radiation Program and a Distinguished Fellow Award from the Office of Health and Environmental Research Health Effects Division (contract no. 03-76SF00098) to M.J.B., the National Cancer Institute (awards R01CA064786, U54CA126552 and U54CA112970 to M.J.B. and R01CA057621 to M.J.B. and Zena Werb), the US Department of Defense Medical and Materiel Command Innovator Award (contract no.W81XWH0810736 and W81XWH0510338) to M.J.B. and postdoctoral fellowships DAMD17-02-1-0441 to R.X. and W81XWH0410581 to V.A.S. and a post-doctoral fellowship to V.A.S. from the Canadian Institutes of Health Research.",

year = "2010",

month = nov,

day = "1",

doi = "10.4161/cc.9.21.13578",

language = "English",

volume = "9",

pages = "4315--4322",

number = "21",

}

TY - JOUR

T1 - Laminin regulates PI3K basal localization and activation to sustain STAT5 activation

AU - Xu, Ren

AU - Spencer, Virginia A.

AU - Groesser, Dinah Levy

AU - Bissell, Mina J.

N1 - Funding Information: We thank Dr. Masahiko Itoh (Dokkyo University Tochigi prefecture, Japan) for providing the ZO-1 antibody. The construct containing STAT5A 1*6 was a kind gift from Dr. Toshio Kitamura (University of Tokyo, Japan). This work was supported by grants from the US Department of Energy, the Office of Biological and Environmental Research (contract no. DE-AC02-05CH1123), a Low Dose Radiation Program and a Distinguished Fellow Award from the Office of Health and Environmental Research Health Effects Division (contract no. 03-76SF00098) to M.J.B., the National Cancer Institute (awards R01CA064786, U54CA126552 and U54CA112970 to M.J.B. and R01CA057621 to M.J.B. and Zena Werb), the US Department of Defense Medical and Materiel Command Innovator Award (contract no.W81XWH0810736 and W81XWH0510338) to M.J.B. and postdoctoral fellowships DAMD17-02-1-0441 to R.X. and W81XWH0410581 to V.A.S. and a post-doctoral fellowship to V.A.S. from the Canadian Institutes of Health Research.

PY - 2010/11/1

Y1 - 2010/11/1

N2 - Extracellular matrix (ECM) is a key regulator of tissue morphogenesis and functional differentiation in the mammary gland. We showed recently that laminin-111 (LN1) together with prolactin induces β-casein expression in mammary epithelial cells (MECs) by sustaining STAT5 activation. Others have shown that Rac1 is required for integrin-mediated STAT5 activation, but molecules upstream of Rac1 remain to be elucidated. Here, we show that exposure to three-dimensional (3D) laminin-rich ECM (LrECM) gels changes the localization of phosphoinositide 3-kinase (PI3K) in MECs from diffuse to basal accompanied with the activation of PI3K-Rac1 signaling pathway. We show by co-immunoprecipitation that Rac1 associates with STAT5, and that LrECM treatment enhances this interaction. Blocking PI3K with LY294002 inhibits LrECM-dependent Rac1 activation, attenuates sustained STAT5 phosphorylation and blocks β-casein gene transcription. These results indicate that PI3K is a key mediator of the LN1-induced signaling cascade which controls the activity of transcription factors essential for tissue-specific gene expression.

AB - Extracellular matrix (ECM) is a key regulator of tissue morphogenesis and functional differentiation in the mammary gland. We showed recently that laminin-111 (LN1) together with prolactin induces β-casein expression in mammary epithelial cells (MECs) by sustaining STAT5 activation. Others have shown that Rac1 is required for integrin-mediated STAT5 activation, but molecules upstream of Rac1 remain to be elucidated. Here, we show that exposure to three-dimensional (3D) laminin-rich ECM (LrECM) gels changes the localization of phosphoinositide 3-kinase (PI3K) in MECs from diffuse to basal accompanied with the activation of PI3K-Rac1 signaling pathway. We show by co-immunoprecipitation that Rac1 associates with STAT5, and that LrECM treatment enhances this interaction. Blocking PI3K with LY294002 inhibits LrECM-dependent Rac1 activation, attenuates sustained STAT5 phosphorylation and blocks β-casein gene transcription. These results indicate that PI3K is a key mediator of the LN1-induced signaling cascade which controls the activity of transcription factors essential for tissue-specific gene expression.

KW - Laminin

KW - PI3K-Rac1 pathway

KW - Polarity

KW - Sustained STAT5 activation

UR - https://www.scopus.com/pages/publications/78349265690

UR - https://www.scopus.com/pages/publications/78349265690#tab=citedBy

U2 - 10.4161/cc.9.21.13578

DO - 10.4161/cc.9.21.13578

M3 - Article

C2 - 20980837

AN - SCOPUS:78349265690

SN - 1538-4101

VL - 9

SP - 4315

EP - 4322

JO - Cell Cycle

JF - Cell Cycle

IS - 21

ER -

Laminin regulates PI3K basal localization and activation to sustain STAT5 activation

Resumen

Nota bibliográfica

Financiación

ASJC Scopus subject areas

Acceder al documento

Otros archivos y enlaces

Huella

Citar esto